News
News
The Arthritis Advocate: Vol.7 – Medication access: Approved does not mean accessible
What does it really mean to have “access” to an arthritis medication? ...
Biosimilars are delivering substantial savings
It's Global Biosimilars Week. Biosimilars are delivering substantial savings—and patients have a stake in protecting that progress ...
Big Pharma’s patent games are costing patients. Congress must act.
A recent article published in The Daily Record highlighted how big pharma's patent games are costing patients. Read the full ...
Access to Care: Pharmaceutical Patents
Once a month, the Crohn's & Colitis Foundation (US) brings all staff together (from all the departments at the Foundation) ...
Crohn’s and Colitis Foundation of the USA on the Patients and patents campaign
In this episode of Arthritis Consumer Experts' Arthritis At Home, host Cheryl Koehn speaks with Laura Wingate, Chief Education, Support, ...
Access to Care: Pharmaceutical Patents Webinar by Crohn’s & Colitis Foundation
This webinar will help you understand patents clearly as well as encourage patients and caregivers to promote more timely availability ...
Australian Patient Advocacy Alliance partners on launch of Patients and patents campaign
In this episode of Arthritis Consumer Experts' Arthritis At Home, host Cheryl Koehn speaks with Deidre Mackechnie, Executive Officer of ...
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
A recent article published on BioSpace summarizes an analysis conducted by Sean Tu of the University of Alabama School of ...
